Position in ATAI
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,850,506
New position
Shares Held
540,893
first reported quarter
Ownership
0.146%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#32
of 239 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOUSSARD & GAVAUDAN GESTION SAS holds $3,292,271 across 2 Biotechnology names. ATAI ranks #1 (86.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ATAI |
AtaiBeckley Inc.
This page
|
540,893 | $2,850,506 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
32,845 | $441,765 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,850,506 | 540,893 | Shares | Sole | 2026-08-19 | |
| No filing history on record for this holder in this stock. | ||||||